Autopsy report · NCT02757417

Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Study never started”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Na
Sponsor: University Hospitals Cleveland Medical Center
Sponsor type: University, hospital or other
Conditions: Ureteral Injury
Interventions: sodium fluorescein; phenazopyridine
Participants: 0
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.